3 recruiting. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 3 |
| Phase 2 | 3 | Recruiting 3 |
Follow Advanced Malignant Neoplasm: new trials by email Literature Review of Advanced Malignant Neoplasm trials Research Report on Advanced Malignant Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors IAP0971 - Advanced Malignant Neoplasm, Advanced or Metastatic Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Recruiting | SUNHO（China）BioPharmaceutical CO., Ltd. | 78 | 2024-12-31 | 2025-01-15 |
| The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) rezatapopt, pembrolizumab - Advanced Solid Tumor, Advanced Malignant Neoplasm | Phase 1 / Phase 2 | Recruiting | PMV Pharmaceuticals, Inc | 300 | 2020-10-29 | 2026-10-02 |
| A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies AMXI-5001:Dose Escalation Phase I, AMXI-5001:Dose Expansion Phase II - Advanced Malignant Neoplasm, Breast Cancer | Phase 1 / Phase 2 | Recruiting | AtlasMedx, Incorporated | 122 | 2020-08-12 | 2025-05-01 |
Breast Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (2) · Ovarian Neoplasms (2) · Prostatic Neoplasms (2) · Colorectal Neoplasms (1) · Disease Progression (1) · Endometrial Neoplasms (1) · Gallbladder Neoplasms (1) · Head and Neck Neoplasms (1) · Lung Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Pancreatic Neoplasms (1) · Small Cell Lung Carcinoma (1) · Triple Negative Breast Neoplasms (1)
Neoplasms by Site (3) · Adnexal Diseases (2) · Breast Diseases (2) · Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Diseases, Male (2) · Genital Neoplasms, Female (2)
Clinical Trials, Phase I as Topic (1) · Clinical Trials, Phase II as Topic (1) · pembrolizumab (1)
AtlasMedx, Incorporated (1) · PMV Pharmaceuticals, Inc (1) · SUNHO（China）BioPharmaceutical CO., Ltd. (1)
United States (2) · Australia (1) · China (1) · France (1) · Germany (1) · Italy (1) · Singapore (1) · South Korea (1) · Spain (1) · United Kingdom (1)
Marc Fellous, MD (1) · Pamela Munster, MD (1)